子宫腺肌症发病机制:分子机制研究进展
子宫腺肌症因影像诊断进步在育龄女性中更常被诊断,其盆腔痛、异常子宫出血和不孕的临床证据改变了其仅为绝经前疾病的经典观念。本文基于截至2016年10月的PubMed检索,综述了疼痛、异常子宫出血和不孕相关的关键分子介质,包括性类固醇激素受体、炎症分子、细胞外基质酶、生长因子和神经血管生成因子,支持子宫腺肌症是独立于子宫内膜异位症的疾病。
要点
- 子宫腺肌症在育龄女性中诊断增加,临床表现包括盆腔痛、异常子宫出血和不孕。
- 子宫腺肌症与子宫内膜异位症共享遗传突变和表观遗传改变,但存在特有的致病通路。
- 关键分子介质包括性类固醇激素受体、炎症分子、细胞外基质酶、生长因子和神经血管生成因子。
核心结论
- 子宫腺肌症是独立于子宫内膜异位症的疾病,具有特定的分子致病机制。
研究设计与样本
- 综述类:检索PubMed截至2016年10月的文献,总结子宫腺肌症疼痛、异常子宫出血和不孕的关键分子介质。
主要发现
- 子宫腺肌症与子宫内膜异位症共享性类固醇激素受体的遗传突变和表观遗传改变及相似炎症介质。
- 近期研究显示子宫腺肌症存在特异性致病通路。
- 关键介质包括性类固醇激素受体、炎症分子、细胞外基质酶、生长因子和神经血管生成因子。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adenomyosis is a uterine disorder becoming more commonly diagnosed in women of reproductive age because of diagnostic imaging advancements. The new epidemiological scenario and the clinical evidence of pelvic pain, abnormal uterine bleeding and infertility are changing the classic perspective of adenomyosis as a premenopausal disease. In the last decade, the evaluation of multiple molecular mediators has improved our knowledge of pathogenic mechanisms of adenomyosis, supporting that this is an independent disease from endometriosis. Although they share common genetic mutations and epigenetic changes in sex steroid hormone receptors and similar inflammatory mediators, an increasing number of recent studies have shown pathogenic pathways specific for adenomyosis. A PubMed search up to October 2016 summarizes the key mediators of pain, abnormal uterine bleeding and infertility in adenomyosis, including sex steroid hormone receptors, inflammatory molecules, extracellular matrix enzymes, growth factors and neuroangiogenic factors.
引用
- Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017. PMID: 28693952. doi:10.1016/j.rbmo.2017.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。